Similar articles

• Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study.

  Jenkins DA, Cowan P, Patrick AW, Clarke BF. Jenkins DA, et al. Nephrol Dial Transplant. 1993;8(3):200-5. Nephrol Dial Transplant. 1993. PMID: 8385284 Clinical Trial.
• Effects of captopril on ambulatory blood pressure, renal and cardiac function in microalbuminuric type 1 diabetic patients.

  Hansen KW, Klein F, Christensen PD, Sørensen K, Andersen PH, Møller J, Pedersen EB, Christiansen JS, Mogensen CE. Hansen KW, et al. Diabete Metab. 1994 Sep-Oct;20(5):485-93. Diabete Metab. 1994. PMID: 7859897 Clinical Trial.
• Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.

  Viberti G, Mogensen CE, Groop LC, Pauls JF. Viberti G, et al. JAMA. 1994 Jan 26;271(4):275-9. JAMA. 1994. PMID: 8295285 Clinical Trial.
• The role of glucagon in the endogenous hyperglycemia of diabetes mellitus.

  Unger RH, Orci L. Unger RH, et al. Annu Rev Med. 1977;28:119-30. doi: 10.1146/annurev.me.28.020177.001003. Annu Rev Med. 1977. PMID: 324351 Review. No abstract available.
• [Effect of the angiotensin I-converting enzyme inhibitor captopril in hypertensive diabetics without nephropathy].

  Gómez Reyes D, Rojas Hidalgo E. Gómez Reyes D, et al. Med Clin (Barc). 1988 Apr 2;90(13):531-4. Med Clin (Barc). 1988. PMID: 3292860 Review. Spanish. No abstract available.